Literature DB >> 19541844

Conditional overexpression of connective tissue growth factor disrupts postnatal lung development.

Shu Wu1, Astrid Platteau, Shaoyi Chen, George McNamara, Jeffrey Whitsett, Eduardo Bancalari.   

Abstract

Connective tissue growth factor (CTGF) is a member of an emerging family of immediate-early gene products that coordinates complex biological processes during development, differentiation, and tissue repair. Overexpression of CTGF is associated with mechanical ventilation with high tidal volume and oxygen exposure in newborn lungs. However, the role of CTGF in postnatal lung development and remodeling is not well understood. In the present study, a double-transgenic mouse model was generated with doxycycline-inducible overexpression of CTGF in respiratory epithelial cells. Overexpression of CTGF from Postnatal Days 1-14 resulted in thicker alveolar septa and decreased secondary septal formation. This is correlated with increased myofibroblast differentiation and disorganized elastic fiber deposition in alveolar septa. Overexpression of CTGF also decreased alveolar capillary network formation. There were increased alpha-smooth muscle actin expression and collagen deposition, and dramatic thickening in the peribronchial/peribronchiolar and perivascular regions in the double-transgenic lungs. Furthermore, overexpression of CTGF increased integrin-linked kinase expression, activated its downstream signaling target, Akt, as well as increased mRNA expression of fibronectin. These data demonstrate that overexpression of CTGF disrupts alveologenesis and capillary formation, and induces fibrosis during the critical period of alveolar development. These histologic changes are similar to those observed in lungs of infants with bronchopulmonary dysplasia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541844      PMCID: PMC2874441          DOI: 10.1165/rcmb.2009-0068OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  54 in total

Review 1.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.

Authors:  Bernard Thébaud; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

Review 2.  The modular architecture of a new family of growth regulators related to connective tissue growth factor.

Authors:  P Bork
Journal:  FEBS Lett       Date:  1993-07-26       Impact factor: 4.124

Review 3.  Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation.

Authors:  G D Massaro; D Massaro
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

4.  ALK-5 mediates endogenous and TGF-beta1-induced expression of connective tissue growth factor in embryonic lung.

Authors:  Shu Wu; Jinghong Peng; Matthew R Duncan; Kalyani Kasisomayajula; Gary Grotendorst; Eduardo Bancalari
Journal:  Am J Respir Cell Mol Biol       Date:  2006-12-29       Impact factor: 6.914

5.  IL-1beta disrupts postnatal lung morphogenesis in the mouse.

Authors:  Kristina Bry; Jeffrey A Whitsett; Urpo Lappalainen
Journal:  Am J Respir Cell Mol Biol       Date:  2006-08-03       Impact factor: 6.914

6.  Inhibition of integrin-linked kinase via a siRNA expression plasmid attenuates connective tissue growth factor-induced human proximal tubular epithelial cells to mesenchymal transition.

Authors:  Bi-Cheng Liu; Min-Xia Li; Jian-Dong Zhang; Xiao-Cong Liu; Xiao-Liang Zhang; Aled O Phillips
Journal:  Am J Nephrol       Date:  2007-10-19       Impact factor: 3.754

7.  Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse.

Authors:  Mark Baguma-Nibasheka; Boris Kablar
Journal:  Dev Dyn       Date:  2008-02       Impact factor: 3.780

8.  Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.

Authors:  Richard A Dean; Georgina S Butler; Yamina Hamma-Kourbali; Jean Delbé; David R Brigstock; José Courty; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

9.  Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice. Prelude to defective alveolar septation during lung development?

Authors:  Richard D Bland; Robert Ertsey; Lucia M Mokres; Liwen Xu; Berit E Jacobson; Shu Jiang; Cristina M Alvira; Marlene Rabinovitch; Eric S Shinwell; Anjali Dixit
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-10-12       Impact factor: 5.464

10.  Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity.

Authors:  S Kotecha; A Wangoo; M Silverman; R J Shaw
Journal:  J Pediatr       Date:  1996-04       Impact factor: 4.406

View more
  28 in total

1.  Glycogen synthase kinase-3β/β-catenin signaling regulates neonatal lung mesenchymal stromal cell myofibroblastic differentiation.

Authors:  Antonia P Popova; J Kelley Bentley; Anuli C Anyanwu; Michelle N Richardson; Marisa J Linn; Jing Lei; Elizabeth J Wong; Adam M Goldsmith; Gloria S Pryhuber; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

2.  Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins.

Authors:  Nard Kubben; Jan Willem Voncken; Gonda Konings; Michel van Weeghel; Maarten Mg van den Hoogenhof; Marion Gijbels; Arie van Erk; Kees Schoonderwoerd; Bianca van den Bosch; Vivian Dahlmans; Chantal Calis; Sander M Houten; Tom Misteli; Yigal M Pinto
Journal:  Nucleus       Date:  2011 May-Jun       Impact factor: 4.197

3.  Recombinant CCN1 prevents hyperoxia-induced lung injury in neonatal rats.

Authors:  Ruben Vaidya; Ronald Zambrano; Julia K Hummler; Shihua Luo; Matthew R Duncan; Karen Young; Lester F Lau; Shu Wu
Journal:  Pediatr Res       Date:  2017-08-02       Impact factor: 3.756

4.  Attenuation of miR-17∼92 Cluster in Bronchopulmonary Dysplasia.

Authors:  Lynette K Rogers; Mary Robbins; Duaa Dakhlallah; Zhaogang Yang; L James Lee; Madison Mikhail; Gerard Nuovo; Gloria S Pryhuber; Gerald McGwin; Clay B Marsh; Trent E Tipple
Journal:  Ann Am Thorac Soc       Date:  2015-10

5.  CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia.

Authors:  Shaoyi Chen; Min Rong; Astrid Platteau; Dorothy Hehre; Heather Smith; Philip Ruiz; Jeffrey Whitsett; Eduardo Bancalari; Shu Wu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

6.  Therapeutic potential of mesenchymal stem cell transplantation in a nitrofen-induced congenital diaphragmatic hernia rat model.

Authors:  Ratih Yuniartha; Fatima Safira Alatas; Kouji Nagata; Masaaki Kuda; Yusuke Yanagi; Genshiro Esumi; Takayoshi Yamaza; Yoshiaki Kinoshita; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2014-08-05       Impact factor: 1.827

7.  Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis.

Authors:  Norihiko Sakai; Andrew M Tager
Journal:  Biochim Biophys Acta       Date:  2013-03-14

Review 8.  Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia.

Authors:  Vineet Bhandari
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-27

9.  Mechanisms of bronchopulmonary dysplasia.

Authors:  Antonia P Popova
Journal:  J Cell Commun Signal       Date:  2013-01-20       Impact factor: 5.782

10.  Molecular control of vascular development by the matricellular proteins CCN1 (Cyr61) and CCN2 (CTGF).

Authors:  Brahim Chaqour
Journal:  Trends Dev Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.